@hemehub.bsky.social๐ฉธ Facts about Smoldering Multiple Myeloma:
The PANGEA risk model, key progression biomarkers, limitations of static risk models, and progression risk across low-, intermediate-, and high-risk SMM.
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #HemeHub
@denekdryden.bsky.socialVyriad and Mayo Clinic are now enrolling patients in a clinical trial to test in vivo CAR-T therapy for #multiplemyeloma.
Instead of taking T-cells from the patient's body and transforming them into CAR-T cells in a lab, this treatment creates the cancer-fighting CAR-T cells within the body.
@naturesfairy.bsky.socialSeptember is Blood Cancer Awareness Month. I was diagnosed with Multiple Myeloma 2018. I have the best medical team at Dana Farber. What helps me get my mind off Cancer is Riding my Bike & Hiking. #multiplemyeloma
#bloodcancerawarenessmonth #bloodcancer #naturesfairy #ridebikesbehappy #youarestrong
@hemehub.bsky.social๐ฏTodayโs questions!
Swipe to see the answers and explanations!
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #Oncology #MedicalEducation #MedEd #ClinicalHematology #Genomics #HemeHub
@hemehub.bsky.social๐ฉธ Facts about Smoldering Multiple Myeloma:
Key SMM risk models include Mayo 2008, PETHEMA, IMWG 20/2/20, cytogenetic risk refinement, and the MGUS-like phenotype.
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #HemeHub
@hemehub.bsky.socialHappening next Friday!
โฎ Register: hemehub.org/live-webinars
#SmolderingMyeloma #MultipleMyeloma #Myeloma #Hematology #HemOnc #Oncology #MedicalEducation #MedEd #HemeHub
@hematologyadvisor.bsky.socialNew from#SOHO2026, follow-up results from the phase 3 DREAMM-7 trial:
BVd triplet demonstrated an OS benefit vs. the DVd triplet in relapsed/refractory #MultipleMyeloma across both ITT and 3+ prior line subgroups over 4+ years of follow-up.
See more details here: https://bit.ly/4r9nUKH
@hemehub.bsky.social๐ข Webinar Update
Our Smoldering Multiple Myeloma webinar with Shaji Kumar, MD and Adeel Khan, MD has been rescheduled following the passing of Robert A. Kyle, MD.
We extend our condolences to his family and the myeloma community.
Register: hemehub.org/live-webinars
@hemehub.bsky.social๐๐กTodayโs questions!
Swipe to see the answers and explanations!
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #Oncology #MedicalEducation #MedEd #ClinicalHematology #HemeHub #Daratumumab #AQUILA #CENTAURUS
@hemehub.bsky.social๐ฉธ Facts about Smoldering Multiple Myeloma:
SLIM-CRAB criteria, precursor stages, immunoparesis, evolving biomarkers, and circulating tumor cells all play a role in assessing SMM progression risk.
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #HemeHub
@pharmaphorum.bsky.social#BristolMyersSquibb's GPRC5D-directed #CARTtherapy, arlocabtagene autoleucel (#arlocel), has shown activity in a phase 2 trial that could underpin future filings for #bloodcancer #multiplemyeloma.
@hemehub.bsky.social๐ฉธ Facts about Smoldering Multiple Myeloma:
Historical origins, IMWG diagnostic criteria, population prevalence, natural progression risk, and the biological heterogeneity of SMM, including its distinction between MGUS-like and myeloma-like disease.
@hemehub.bsky.social๐๐ฏFirst clinical questions of the month!
Swipe to see the answers and explanations!
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Myeloma #PlasmaCellDisorders #MGUS #IMWG #Hematology #HemeOnc #Oncology #ClinicalHematology #MedicalEducation #MedEd #HemeHub
@hemehub.bsky.social๐ฉธ๐ข The links for the HemeHub Hematology Summit have been updated!
Registration: hemehub.org/events/hemeh...
Full program and event details:
hemehub.org/events/hemeh...
๐๏ธ October 3, 2026
๐ Gaylord Texan Resort & Convention Center
#HemeHub #HemeOnc #Myelofibrosis #MultipleMyeloma #CLL #PNH #DLBCL
@fmpe-femc.bsky.social๐๐ฎ๐ซ ๐ฆ๐จ๐๐ฎ๐ฅ๐ ๐จ๐ง: ๐๐ฎ๐ฅ๐ญ๐ข๐ฉ๐ฅ๐ ๐๐ฒ๐๐ฅ๐จ๐ฆ๐ ๐๐ง๐ ๐๐จ๐ง๐จ๐๐ฅ๐จ๐ง๐๐ฅ ๐๐๐ฆ๐ฆ๐จ๐ฉ๐๐ญ๐ก๐ฒ ๐จ๐ ๐๐ง๐๐๐ญ๐๐ซ๐ฆ๐ข๐ง๐๐ ๐๐ข๐ ๐ง๐ข๐๐ข๐๐๐ง๐๐ ๐ข๐ฌ ๐ง๐จ๐ฐ ๐๐ฏ๐๐ข๐ฅ๐๐๐ฅ๐ ๐ญ๐จ ๐๐ฅ๐ฅ ๐ฆ๐๐ฆ๐๐๐ซ๐ฌ. ๐
Not a member? ๐ค Find out more on how to join: fmpe.org/our-program/...
#MultipleMyeloma #MGUS #SmolderingMultipleMyeloma #PrimaryCare #FamilyMedicine #MedicalEducation
@vcclibrary.bsky.socialGPRC5D-targeting bispecific and trispecific antibodies in #MultipleMyeloma: Current evidence and emerging strategies. acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
@hemehub.bsky.social๐ฉธThis Month on HemeHub: Smoldering Multiple Myeloma
Explore risk stratification, evolving biomarkers, and emerging treatment approaches for high-risk SMM.
๐๏ธLive Webinar: Shaji Kumar, MD & Adeel Khan, MD โ This Friday!
๐ hemehub.org
@hemehub.bsky.social๐ฉธ Happening this Friday!
โฎ Register: hemehub.org/live-webinars
โฎ Submit your cases: hemehub.org/case-submiss...
#SmolderingMyeloma #MultipleMyeloma #Hematology #HemOnc #Oncology #MedEd #HemeHub